You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 10, October 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Macular Disorders
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Visual Field Defects After Intravitreous Administration of Indocyanine Green in Macular Hole Surgery

Shigeru Kanda, MD; Akinori Uemura, MD; Takehiro Yamashita, MD; Hazuki Kita, MD; Keita Yamakiri, MD; Taiji Sakamoto, MD

Arch Ophthalmol. 2004;122:1447-1451.

Objectives  To report the findings on a patient cohort with visual field defects after macular hole surgery with indocyanine green (ICG)–assisted internal limiting membrane peeling and to investigate the correlation between the defects and the use of ICG.

Design  Retrospective, noncomparative interventional case series.

Participants  Thirty-nine eyes of 38 patients having the clinical diagnosis of a macular hole who underwent pars plana vitrectomy between January 1, 2001, and December 31, 2002, were enrolled in this study.

Intervention  Indocyanine green–assisted internal limiting membrane peeling was performed on a series of 22 eyes: 12 eyes using a 0.5% ICG solution and 3-minute exposure to the retina (group 1), 4 eyes using a 0.5% ICG solution and immediate washout (group 2), and 6 eyes using a 0.25% ICG solution and immediate washout (group 3). The remaining 17 eyes underwent vitrectomy without ICG-assisted internal limiting membrane peeling (group 4).

Main Outcome Measures  Visual field, best-corrected visual acuity, and fundus photography were evaluated.

Results  Postoperatively, all patients (100%) in group 1 and 1 (25%) of 4 eyes in group 2 had visual field defects. None of the patients in group 3 had a visual field defect. The visual field defects included 10 eyes (84%) with nasal defects, 1 eye (8%) with an inferotemporal defect, and 1 eye (8%) with an extensive visual field defect. Ophthalmoscopy revealed mild to moderate optic disc pallor in 8 (62%) of 13 eyes with postoperative visual field defects. Only 1 patient in group 4 had an inferotemporal defect; none of the other patients in group 4 had visual field defects. There was no statistically significant difference in postoperative visual acuity between patients with and without postoperative visual field defects.

Conclusions  Although this study was limited by the few patients enrolled, our experience indicates that visual field defects, specifically nasal defects, can occur after macular hole surgery with ICG-assisted internal limiting membrane peeling, and that the incidence depends on the concentration of the ICG solution and/or the exposure time to the retina. Further studies are needed to clarify the pathomechanism of visual field defects.


From the Department of Ophthalmology, Kagoshima City Hospital (Drs Kanda, Uemura, Yamashita, and Kita), and the Department of Ophthalmology, Kagoshima University Graduate School of Medicine and Dental Sciences (Drs Kanda, Yamashita, Yamakiri, and Sakamoto), Kagoshima, Japan. The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial
Christensen et al.
Br J Ophthalmol 2009;93:1005-1015.
ABSTRACT | FULL TEXT  

Staining and peeling of the internal limiting membrane using a fluorescent dye (Rhodamine 6 G)
Haritoglou et al.
Br J Ophthalmol 2008;92:1265-1268.
ABSTRACT | FULL TEXT  

Intraoperative extraocular Indocyanine Green (IE-ICG) dye test: a new method of detecting a peeled internal limiting membrane
Park et al.
Br J Ophthalmol 2008;92:369-372.
ABSTRACT | FULL TEXT  

Vitreoretinal surgery using bromphenol blue as a vital stain: evaluation of staining characteristics in humans
Haritoglou et al.
Br J Ophthalmol 2007;91:1125-1128.
ABSTRACT | FULL TEXT  

Residual indocyanine green fluorescence pattern after vitrectomy for idiopathic macular hole with internal limiting membrane peeling
Sayanagi et al.
Br J Ophthalmol 2007;91:939-944.
ABSTRACT | FULL TEXT  

Relationship between macular hole size and the potential benefit of internal limiting membrane peeling.
Williams
Br J Ophthalmol 2006;90:1216-1217.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.